Latest Breaking News On - Marketing authorization - Page 9 : comparemela.com

Sosei Group Announces Marketing Approval for PIVLAZ™ (clazosentan sodium) 150 mg in South Korea

PIVLAZ™, a new drug for prevention of Cerebral Vasospasm in patients with Aneurysmal Subarachnoid Hemorrhage (aSAH), approved in South KoreaPIVLAZ.

United kingdomCity ofSoult ukpyolsiSouth koreaKyonggi doJ clin neurosciErica hollingsworthSosei heptaresSatoshi tanakaFrazer hallMaya bennisonKentaro taharaShinichiro nishishitaSosei group corporationTokyo stock exchangeMinistry of food

Sosei Group Corporation Announces Marketing Approval for PIVLAZ (Clazosentan Sodium) 150 Mg in South Korea

Sosei Group Corporation announced that PIVLAZ 150 mg has received marketing approval from the Ministry of Food and Drug Safety in South Korea for the prevention of cerebral vasospasm,.

South koreaSosei group corporationMinistry of foodSosei groupIdorsia pharmaceuticals japanIdorsia pharmaceuticals koreaDrug safetyJapanese phaseMarketing authorization

Sosei Group Announces Marketing Approval for PIVLAZ™

Sosei Group Announces Marketing Approval for PIVLAZ™
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Kyonggi doSouth koreaCity ofUnited kingdomSoult ukpyolsiMaya bennisonSosei heptaresKentaro taharaJ clin neurosciSatoshi tanakaErica hollingsworthShinichiro nishishitaFrazer hallMedistrava consulting for international mediaIdorsia pharmaceuticals korea co ltdTokyo stock exchange

Vertex Announces European Medicines Agency Validation for Marketing Authorization Application Extension for KAFTRIO in Combination with Ivacaftor to Include People with Cystic Fibrosis and Responsive Rare Mutations

LONDON - Vertex Pharmaceuticals today announced that the European Medicines Agency has validated a Type II variation application to the Marketing Authorization for KAFTRIO in combination with.

City ofUnited kingdomVertex pharmaceuticals nasdaqEuropean medicines agencyEuropean commissionCommittee for medicinal products human useMedicines agencyMarketing authorizationMedicinal productsHuman useNews publishing

Vertex Pharmaceuticals: Vertex Announces European Medicines Agency Validation for Marketing Authorization Application Extension for KAFTRIO in Combination With Ivacaftor to Include People With Cystic Fibrosis and Responsive Rare Mutations

Vertex Pharmaceuticals: Vertex Announces European Medicines Agency Validation for Marketing Authorization Application Extension for KAFTRIO in Combination With Ivacaftor to Include People With Cystic Fibrosis and Responsive Rare Mutations
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

New zealandUnited statesFrance generalCity ofUnited kingdomIsabelle fajacStefan klotterVertex pharmaceuticals incorporatedCompanies to workVertex pharmaceuticals nasdaqCommittee for medicinal products human useEuropean unionEuropean commissionExchange commissionEuropean medicines agencyMarketing authorization